Consistently, our results emphasize that aggressive signature and metastatic capability of ESCC is inextricably linked to the crosstalk of Wnt/Notch signaling cascades with activation of the downstream target genes, such as MMP-21, HLA-G, and IL-10. This evidence concerns the gene IL10 and esophageal squamous cell carcinoma.